Literature Highlights - August 2023
This highlight deck is comprised of 4 papers
Each month the Lupus Forum Steering Committee selects the latest published original articles on Lupus, focusing on those with data on therapeutic interventions and those that have clinical impact.
Literature Highlights - July 2023
This highlight deck is comprised of 4 papers
Keywords:
Medication cost, Voclosporin, RIFLE-LN, Neuropsychiatric lupus
Literature Highlights - June 2023
This highlight deck is comprised of 5 papers
Keywords:
Belimumab, Antimalarials, Extra-renal SLE, BI 655064, Remission, Infection risk, Rituximab, Neuropsychiatric flares
Literature Highlights - May 2023
This highlight deck is comprised of 4 papers
Keywords:
Litifilimab, Cutaneous lupus erythematosus, Longitudinal autoantibody profiles, Belimumab, Anifrolumab, RISE
Literature Highlights - April 2023
This highlight deck is comprised of 5 papers
Keywords:
Glucocorticoid tapering, Anifrolumab, Remission, ClinRO, PROs
Literature Highlights - March 2023
This highlight deck is comprised of 6 papers
Keywords:
Baricitinib, EULAR, Interferon production, Lupus nephritis, Belimumab
Literature Highlights - February 2023
This highlight deck is comprised of 5 papers
Keywords:
Neuropsychiatric disease, Economic burden, EULAR, ACR, Organ damage, LLDAS, Anifrolumab, Fatigue, QoL, PROs, Transcriptomic signature
Literature Highlights - January 2023
This highlight deck is comprised of 5 papers
Keywords:
Evobrutinib, Biologics, Systematic review, DMARDs, Belimumab, Pregnancy, Dapirolizumab, Real-world, Childhood-onset SLE
Literature Highlights - December 2022
This highlight deck is comprised of 4 papers
Keywords:
Biologics, B-lymphocytes, Biomarkers, Deucravacitinib, TYK2, Phase II, Anifrolumab, Phase III, Long-term, Safety, Interleukin-2, Treg
Literature Highlights - November 2022
This highlight deck is comprised of 3 papers